Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Structure Therapeutics Inc. Sponsored ADR (GPCR) Debt to Equity Ratio data is not available.
| Income Statement Financials | |
-- |
|
$-65.71M |
|
-- |
|
-- |
|
$73.79M |
|
$-73.79M |
|
$8.18M |
|
$-65.60M |
|
$-65.60M |
|
$-65.71M |
|
$-65.71M |
|
$-65.71M |
|
$-65.71M |
|
$-73.79M |
|
$-76.72M |
|
58.49M |
|
58.49M |
|
$-1.12 |
|
$-1.12 |
|
| Balance Sheet Financials | |
$814.02M |
|
$4.67M |
|
$18.14M |
|
$832.16M |
|
$57.53M |
|
-- |
|
$4.61M |
|
$62.14M |
|
$770.02M |
|
$770.02M |
|
$770.02M |
|
60.68M |
|
| Cash Flow Statement Financials | |
$-157.78M |
|
$33.66M |
|
$57.53M |
|
$169.51M |
|
$102.91M |
|
$-66.60M |
|
$20.92M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.15 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-159.90M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-8.53% |
|
-8.53% |
|
-7.90% |
|
-8.53% |
|
$12.69 |
|
$-2.73 |
|
$-2.70 |
|